When.com Web Search

  1. Ads

    related to: viagra price uk tadalafilise free

Search results

  1. Results From The WOW.Com Content Network
  2. How to Pay the Lowest Price for Cialis & Tadalafil - AOL

    www.aol.com/lifestyle/pay-lowest-price-cialis...

    The price per dose of Viagra is higher than Cialis. Viagra ranges from $86 to $116 a pill. Meanwhile, Cialis is more like $15 to $83 per dose, depending on the dosage and whether it’s the daily ...

  3. Sildenafil - Wikipedia

    en.wikipedia.org/wiki/Sildenafil

    Sildenafil, sold under the brand name Viagra among others, is a medication used to treat erectile dysfunction and pulmonary arterial hypertension. [4] [8] It is also sometimes used off-label for the treatment of certain symptoms in secondary Raynaud's phenomenon. [9]

  4. How to Get Better Viagra Results in 2025 - AOL

    www.aol.com/better-viagara-results-2025...

    Viagra isn’t the only PDE5 inhibitor on the market. In fact, the FDA has approved three other PDE5 inhibitors to help treat the symptoms of ED: Cialis (tadalafil) Levitra (vardenafil)

  5. Got Headaches from Viagra or Cialis? Here's Why & How to Treat It

    www.aol.com/got-headaches-viagra-cialis-heres...

    In one study of Viagra published in the journal Urology in 2000, researchers noted that a relatively high dose of Viagra or another ED medication may cause a higher risk of developing headaches ...

  6. PDE5 inhibitor - Wikipedia

    en.wikipedia.org/wiki/PDE5_inhibitor

    Chemical structure of sildenafil (Viagra), the prototypical PDE5 inhibitor. A phosphodiesterase type 5 inhibitor (PDE5 inhibitor) is a vasodilating drug that works by blocking the degradative action of cGMP-specific phosphodiesterase type 5 (PDE5) on cyclic GMP in the smooth muscle cells lining the blood vessels supplying various tissues.

  7. Pharmaceutical Price Regulation Scheme - Wikipedia

    en.wikipedia.org/wiki/Pharmaceutical_Price...

    The Pharmaceutical Price Regulation Scheme (PPRS) is the mechanism used by the UK Department of Health to ensure that the NHS has access to good quality branded medicines at reasonable prices. It involves a non-contractual agreement between the UK Department of Health and The Association of the British Pharmaceutical Industry (ABPI).